| Code | CSB-RA008540MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to VIB-9600, targeting FCGR2A (Fc gamma receptor IIA, also known as CD32A). FCGR2A is a low-affinity IgG receptor expressed primarily on myeloid cells, including monocytes, macrophages, neutrophils, and dendritic cells. This receptor plays a critical role in immune complex-mediated phagocytosis, antibody-dependent cellular cytotoxicity, and inflammatory responses. FCGR2A exhibits functional polymorphisms that influence individual susceptibility to autoimmune diseases, infectious diseases, and therapeutic antibody responses. Its dysregulation has been implicated in systemic lupus erythematosus, rheumatoid arthritis, and immune thrombocytopenia.
VIB-9600 is an established research tool used to investigate FCGR2A expression, function, and signaling pathways in immune cells. This biosimilar antibody provides researchers with a reliable reagent for studying Fc receptor-mediated immune mechanisms, evaluating therapeutic antibody interactions, and exploring the role of FCGR2A in inflammatory and autoimmune conditions. It serves as a valuable tool for immunology research and disease mechanism studies.
There are currently no reviews for this product.